Hicin Pharmaceutical Jointly Invests Into 20 Million Yuan New Materials Venture

MT Newswires Live2025-01-16

Nanjing Hicin Pharmaceutical (SHE:300584) plans to jointly establish a 20 million yuan venture with a number of investors, according to a Shenzhen Stock Exchange disclosure on Wednesday.

The planned venture, Sichuan Luochen New Materials Technology, will produce and sell technology patent licensing and technical services of new energy and electronic materials.

The pharmaceutical company, through subsidiary Anqing Huichen Technology, will invest 8.2 million yuan into the venture, accounting for 41% of its capital.

The other venture partners are Sichuan Saike Power Technology, Yibin Ronggu New Materials Technology Center (Limited Partnership), the company's director Cao Xichen and individual investor Yan Meiqiang.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

精彩評論

我們需要你的真知灼見來填補這片空白

發表看法

{"i18n":{"language":"zh_TW"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2503952211?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-16 16:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2503952211","market":"nz","top_or_hot":-1,"title":"Hicin Pharmaceutical Jointly Invests Into 20 Million Yuan New Materials Venture","media":"MT Newswires Live","content":"<html><body><p> Nanjing Hicin Pharmaceutical (SHE:300584) plans to jointly establish a 20 million yuan venture with a number of investors, according to a Shenzhen Stock Exchange disclosure on Wednesday.</p><p>The planned venture, Sichuan Luochen New Materials Technology, will produce and sell technology patent licensing and technical services of new energy and electronic materials.</p><p>The pharmaceutical company, through subsidiary Anqing Huichen Technology, will invest 8.2 million yuan into the venture, accounting for 41% of its capital.</p><p>The other venture partners are Sichuan Saike Power Technology, Yibin Ronggu New Materials Technology Center (Limited Partnership), the company's director Cao Xichen and individual investor Yan Meiqiang.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hicin Pharmaceutical Jointly Invests Into 20 Million Yuan New Materials Venture</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHicin Pharmaceutical Jointly Invests Into 20 Million Yuan New Materials Venture\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-01-16 16:57</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Nanjing Hicin Pharmaceutical (SHE:300584) plans to jointly establish a 20 million yuan venture with a number of investors, according to a Shenzhen Stock Exchange disclosure on Wednesday.</p><p>The planned venture, Sichuan Luochen New Materials Technology, will produce and sell technology patent licensing and technical services of new energy and electronic materials.</p><p>The pharmaceutical company, through subsidiary Anqing Huichen Technology, will invest 8.2 million yuan into the venture, accounting for 41% of its capital.</p><p>The other venture partners are Sichuan Saike Power Technology, Yibin Ronggu New Materials Technology Center (Limited Partnership), the company's director Cao Xichen and individual investor Yan Meiqiang.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ARKG","symbol_name":"ARK Genomic Revolution ETF","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2503952211","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2503952211","pubTimestamp":1737017879,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Nanjing Hicin Pharmaceutical  plans to jointly establish a 20 million yuan venture with a number of investors, according to a Shenzhen Stock Exchange disclosure on Wednesday.The planned venture, Sichuan Luochen New Materials Technology, will produce and sell technology patent licensing and technical services of new energy and electronic materials.The pharmaceutical company, through subsidiary Anqing Huichen Technology, will invest 8.2 million yuan into the venture, accounting for 41% of its capital.The other venture partners are Sichuan Saike Power Technology, Yibin Ronggu New Materials Technology Center , the company's director Cao Xichen and individual investor Yan Meiqiang.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300584":"海辰药业","ARKG":"ARK Genomic Revolution ETF","BK0239":"医药制造"},"translate_title":"海鑫药业联合投资2000万元新材料企业","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300584":0.9,"ARKG":1},"content_text":"Nanjing Hicin Pharmaceutical (SHE:300584) plans to jointly establish a 20 million yuan venture with a number of investors, according to a Shenzhen Stock Exchange disclosure on Wednesday.The planned venture, Sichuan Luochen New Materials Technology, will produce and sell technology patent licensing and technical services of new energy and electronic materials.The pharmaceutical company, through subsidiary Anqing Huichen Technology, will invest 8.2 million yuan into the venture, accounting for 41% of its capital.The other venture partners are Sichuan Saike Power Technology, Yibin Ronggu New Materials Technology Center (Limited Partnership), the company's director Cao Xichen and individual investor Yan Meiqiang.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2503952211?edition=fundamental&lang=zh_TW","isCrawlerRequest":true}